Gaudium IVF IPO Date, Price, GMP, Review & Full Details 2026

The Gaudium IVF IPO date is on Friday, February 20, 2026; the closing date will be Tuesday, February 24, 2026. It is a bookbuilding IPO, and the Gaudium IVF IPO price band is ₹ 75 to 79 per share. The ₹165 crore mix of fresh capital issue and offer of sale (OFS) is part of the public issue.

It is indicated that, following the matter, equity shares will be listed in BSE and NSE on Friday, February 27, 2026. The corporate company has a pre-IPO market value of INR 575.02 crore and the funds will be utilized in the business expansion and other corporate operations. At Trendy Traders Academy we are going to address Gaudium IVF Centre details, How to apply in India, Key investment considerations, etc.

Gaudium IVF IPO Dates & Timeline

Event	Date
IPO Open Date	Fri, Feb 20, 2026
IPO Close Date	Tue, Feb 24, 2026
Basis of Allotment	Wed, Feb 25, 2026
Refund Initiation	Wed, Feb 25, 2026
Credit of Shares	Thu, Feb 26, 2026
IPO Listing Date	Fri, Feb 27, 2026

About Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited is one such company that was established in March 2015 and it possesses particular fertility centres in India. The targets of the firm include assisted reproductive technologies including:

IVF (In Vitro Fertilization)
ICSI procedures
IUI treatments
Fertility preservation
High-tech reproductive diagnostics.
Women’s healthcare services

The Gaudium IVF Centre adheres to the hub-and-spoke business model where several fertility centres are running in India. This system has the advantage of centralized medical experience, as well as increased access to services in various areas.

Indian IVF market can be characterized by the following

Increasing awareness
Lifestyle changes
Rising disposable income
Medical advancements
Increased acceptance of fertility procedures.

This business environment poses a long term growth opportunity to organised IVF chains such as Gaudium IVF.

Gaudium IVF IPO - Key Highlights

Aspect	Detail
Company	Gaudium IVF and Women Health Limited
Issue Type	Book-built IPO
Gaudium IVF IPO Date	Feb 20-24, 2026
Gaudium IVF IPO Price Band	₹75 to ₹79 per share
Face Value	₹5 per equity share
Lot size	189 shares
Total Shares Offered	2,08,86,200 equity shares (₹165 Cr)
Fresh Issue	1,13,92,500 shares (₹90 Cr)
Offer for Sale (OFS)	94,93,700 shares
Listing On	BSE & NSE

What is Gaudium IVF IPO?

The Gaudium IVF and Women Health Limited IPO is one of the most discussed healthcare IPOs on India’s primary market in 2026. Gaudium IVF Centre provides the investors with an exposure to the rapidly growing fertility and reproductive healthcare sector in India – a segment that is growing as a result of increased infertility awareness, late parenthood, and the increasing medical infrastructure.

When it comes to Indian investors, the niche healthcare segments of IPOs are usually promising high growth potential. But it is necessary to discipline the analysis – verification of GMP trends, subscription data, and fundamentals – prior to application.

Gaudium IVF IPO Price Band

It offers the IPO at a price band of ₹75 to ₹79 per equity share, and the face value of ₹5 per equity share. At the high price band of ₹79, they will have to invest in ₹14,931 per lot since the lot size is limited to 189 shares.

The Gaudium IVF IPO Price Band aims to show the company valuation and growth prospects, and the bookbuilding initiative will show the final deal price depending on the demand of investors in the retail, HNI, and QIB classes.

Investors can check:

Their broker app
NSE/BSE websites
Chittorgarh.com
Investorgain.com

These platforms display live IPO price band updates, lot size and minimum investment amount.

Face Value

The face value of equity shares is ₹5 per share.

Gaudium IVF IPO GMP (Grey Market Premium)

Grey Market Premium reflects the unofficial trading price of IPO shares before listing. It helps investors gauge market sentiment.

If the Gaudium IVF IPO GMP is:

Above 20% → One can consider applying for potential listing gains
Around 0% → Neutral sentiment
Negative → Weak demand

Investors should regularly monitor GMP updates on:

Chittorgarh.com
Investorgain.com

However, remember that Gaudium IVF IPO GMP is unofficial and can fluctuate daily based on demand and market mood.

Financial Performance Snapshot

Strong IPO decisions require analysing financial data.

Latest available numbers indicate:

Revenue: ₹70+ crore range
Profit After Tax: ₹19+ crore
EBITDA: ₹28+ crore
Net Worth: ₹46+ crore

Key financial factors to evaluate

Revenue growth trend
PAT margin
Return on Net Worth
Debt levels
Cash flows

Healthcare IPOs with strong profit margins and low debt tend to attract better investor response.

Why is This IPO Important for Indian Investors?

India’s fertility sector is expanding rapidly due to:

Late marriages and delayed parenthood
Rising infertility rates
Greater acceptance of IVF
Tier-2 and Tier-3 city expansion
Higher medical insurance coverage

The organised IVF chain model is still underpenetrated in India. Companies with strong branding and medical expertise may benefit from long-term industry growth.

For Gaudium IVF Centre IPO investors, the opportunity lies in:

Listing gains (short term)
Long-term sector growth (long term)

How to Apply for Gaudium IVF IPO in India?

You can apply through:

ASBA via Net Banking: Using ASBA, login to your bank’s IPO section and apply.
UPI via Broker: Use your trading app (Zerodha, Groww, Angel One, etc.) and approve the UPI mandate.
Offline Application: Through registered brokers.

Funds remain blocked until allotment finalisation.

IPO Subscription Strategy for Retail Investors

Before applying:

Check GMP daily
Review subscription numbers (Retail, QIB, HNI categories)
Compare valuation with peers
Check overall market sentiment
Avoid over-allocating capital to one IPO

If GMP is consistently above 20% and subscription numbers are strong, applying may be considered.

Risks to Consider

Every IPO carries risks. For Gaudium IVF IPO, investors should evaluate:

Competition in IVF industry
Regulatory healthcare norms
Dependency on skilled doctors
Geographic expansion challenges

IPO listing gains are never guaranteed. Market conditions at listing date play a critical role.

How to Track IPO Performance After Listing?

After listing:

Track price movement on NSE/BSE
Compare listing price vs issue price
Watch volume trends
Review quarterly earnings

Some IPOs perform well on listing day but correct later. A disciplined exit plan is essential.

Key Investment Checklist

Before investing in Gaudium IVF IPO:

Check Gaudium IVF IPO Date and Gaudium IVF IPO Price Band
Review Financials
Monitor GMP
Check subscription levels
Assess valuation
Ensure diversification

Never invest just because it is being hyped.

Conclusion

Gaudium IVF and Women Health Limited IPO provides the Indian investors with an opportunity to be exposed to the growing fertility healthcare industry. The company has the ability to operate in an encouraging niche, as it moves forward in terms of increased awareness, increased demand and coordinated operations.

However, smart IPO investing requires discipline. Monitor GMP trends on Chittorgarh.com and Investorgain.com. If GMP exceeds 20% and subscription data supports demand, applying may be considered for potential listing gains.

Disclaimer

The article is educational and informational in nature. The investments in IPOs are exposed to the risks of the market such as the risk of capital loss. Before investing, the readers should do their own research or hire a certified financial advisor.

Also Read : How to check PPF balance Online? (Public Provident Fund)